Related Experiment Video
Updated: May 9, 2026

The Lambda Select cII Mutation Detection System
Published on: April 26, 2018
In vivo cII, gpt, and Spi⁻ gene mutation assays in transgenic mice and rats
Mugimane G Manjanatha1, Xuefei Cao, Sharon D Shelton
1Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, USA.
Abstract:
Transgenic mutation assays are used to identify and characterize genotoxic hazards and for determining the mode of action for carcinogens. The three most popular transgenic mutational models are Big Blue® (rats or mice), Muta™ mouse (mice), and gpt-delta (rats or mice). The Big Blue® and Muta™ mouse models use the cII gene as a reporter of mutation whereas gpt-delta rodents use the gpt gene and the red/gam genes (Spi⁻ selection) as mutation reporter genes. Here we describe methodology for conducting mutation assays with these transgenes. Transgenes recovered from tissue DNA are packaged into infectious lambda phage, bacteria are infected with the phage, and cII-mutant and Spi⁻ plaques and gpt-mutant colonies are isolated using selective conditions and quantified. Selected mutants can be further analyzed for identification of small sequence alterations in the cII and gpt genes and large deletions at the Spi⁻ locus.
Insights
This study details methods for transgenic mutation assays using Big Blue®, Muta™ mouse, and gpt-delta models. These assays identify genotoxic hazards and carcinogen mechanisms by analyzing reporter gene mutations in rodents.
Area of Science:
- Toxicology and Genetic Toxicology
- Molecular Biology and Carcinogenesis
Background:
- Transgenic mutation assays are crucial for identifying genotoxic hazards and understanding carcinogen mechanisms.
- Popular models include Big Blue® (rat/mouse), Muta™ mouse, and gpt-delta (rat/mouse), each utilizing distinct reporter genes.
Purpose of the Study:
- To describe standardized methodologies for conducting mutation assays in established transgenic rodent models.
- To provide a framework for the recovery, analysis, and quantification of mutations in reporter genes.
Main Methods:
- Isolation of transgenes from tissue DNA.
- Packaging of transgenes into lambda phage for bacterial infection.
- Selective isolation and quantification of mutant plaques (cII, Spi⁻) and colonies (gpt).
Main Results:
- Detailed procedures for implementing mutation assays in Big Blue®, Muta™ mouse, and gpt-delta systems.
- Methodology allows for the quantification of mutations within specific reporter genes (cII, gpt) and loci (Spi⁻).
Conclusions:
- The described methodologies enable robust characterization of genotoxic effects and carcinogen modes of action.
- Further analysis of selected mutants can identify specific sequence alterations and large deletions.
Related Concept Videos
In-vitro Mutagenesis
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
In vitro Mutagenesis

